RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.
A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
- Chemical Identification
- Environmental Hazards
- First Aid/Medical Treatment
- Handling/Storage/Shipping/Waste Management
- Personal Protection
- Physical Hazards/Corrective Response Actions
- Physical/Chemical Properties
- Report Abstracts and Studies
- Reproductive Risk
- Toxicology/Health Hazards/Exposure
|Example of Acute Exposure data from MEDITEXT.|
RightAnswer Proprietary Data Sources:
Other Government Links Searched via RegsKnowledge:
State Environmental Regulations
Example Content from MEDITEXT for Rufinamide:
Please note: this is an extract of information from a larger document. Full document and details are available by subscription.
ACUTE EXPOSURE INFORMATION
- USES: A triazole derivative used to treat seizures associated with Lennox-Gastaut syndrome in adults and in children 4 years of age and older.
- PHARMACOLOGY: The exact mechanism of action is unknown. In vitro studies suggest that rufinamide modulates the activity of sodium channels and subsequently prolongs the inactive state of the channel.
- EPIDEMIOLOGY: Overdose is very rare.
- WITH THERAPEUTIC USE
- ADVERSE EFFECTS: COMMON: Somnolence, nausea, vomiting, headache, fatigue, and dizziness. Other adverse effects that may occur: decreased appetite, rash, pruritus, ataxia, diplopia, blurred vision, abdominal pain, multiorgan hypersensitivity syndrome, shortening of the QT interval, and suicidal thinking or behavior.
- WITH POISONING/EXPOSURE
- MILD TO MODERATE TOXICITY: Overdose information is limited. An adult received an overdose of 7200 mg/day of rufinamide during the clinical trials and did not experience any major adverse effects.
- SEVERE TOXICITY: Based on limited data, none reported.
© 2011-2017 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.